Common Stock, Shares, Issued of Enlivex Therapeutics Ltd. from 31 Dec 2013 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2013 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Common Stock, Shares, Issued for the quarter ending 30 Jun 2025 was 23,858,301, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 23,858,301 +2,974,989 +14% 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q4 2024 23,650,989 +5,052,434 +27% 31 Dec 2024 6-K 29 Aug 2025 2025 Q2
Q2 2024 20,883,312 +2,294,173 +12% 30 Jun 2024 6-K 30 Aug 2024 2024 Q2
Q4 2023 18,598,555 +176,703 +0.96% 31 Dec 2023 20-F 30 Apr 2025 2024 FY
Q2 2023 18,589,139 +208,087 +1.1% 30 Jun 2023 6-K 01 Sep 2023 2023 Q2
Q4 2022 18,421,852 +90,345 +0.49% 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q2 2022 18,381,052 +74,866 +0.41% 30 Jun 2022 6-K 22 Aug 2022 2022 Q2
Q4 2021 18,331,507 +3,743,573 +26% 31 Dec 2021 20-F 10 Apr 2023 2022 FY
Q2 2021 18,306,186 +4,842,415 +36% 30 Jun 2021 6-K 06 Aug 2021 2021 Q2
Q4 2020 14,587,934 +4,253,808 +41% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q2 2020 13,463,771 30 Jun 2020 6-K/A 13 Oct 2020 2020 Q2
Q1 2020 2,093,750 05 Mar 2020 6-K/A 13 Oct 2020 2020 Q2
Q4 2019 10,334,126 +6,824,721 +194% 31 Dec 2019 20-F 30 Apr 2021 2020 FY
Q4 2018 3,509,405 +3,090,941 +739% 31 Dec 2018 20-F 30 Apr 2020 2019 FY
Q4 2017 418,464 -2,860,023 -87% 31 Dec 2017 20-F/A 23 Jan 2020 2018 FY
Q4 2016 3,278,487 -10,951,993 -77% 31 Dec 2016 20-F 23 Apr 2018 2017 FY
Q4 2015 14,230,480 0 0% 31 Dec 2015 20-F 24 Feb 2017 2016 FY
Q4 2014 14,230,480 +5,047,613 +55% 31 Dec 2014 20-F 29 Mar 2016 2015 FY
Q4 2013 9,182,867 31 Dec 2013 20-F 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.